Cargando…
Daptomycin use in patients with osteomyelitis: a preliminary report from the EU-CORE(SM) database
BACKGROUND: Osteomyelitis is a complex and heterogeneous group of infections that require surgical and antimicrobial interventions. Because treatment failure or intolerance is common, new treatment options are needed. Daptomycin has broad Gram-positive activity, penetrates bone effectively and has b...
Autores principales: | Seaton, R. Andrew, Malizos, Konstantinos N., Viale, Pierluigi, Gargalianos-Kakolyris, Panagiotis, Santantonio, Teresa, Petrelli, Enzo, Pathan, Rashidkhan, Heep, Markus, Chaves, Ricardo L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3682689/ https://www.ncbi.nlm.nih.gov/pubmed/23515247 http://dx.doi.org/10.1093/jac/dkt067 |
Ejemplares similares
-
Daptomycin in the Clinical Setting: 8-Year Experience with Gram-positive Bacterial Infections from the EU-CORE(SM) Registry
por: Gonzalez-Ruiz, Armando, et al.
Publicado: (2015) -
Real-world daptomycin use across wide geographical regions: results from a pooled analysis of CORE and EU-CORE
por: Seaton, R. Andrew, et al.
Publicado: (2016) -
Daptomycin for the Treatment of Infective Endocarditis: Results from European Cubicin(®) Outcomes Registry and Experience (EU-CORE)
por: Guleri, Achyut, et al.
Publicado: (2015) -
Real-World Treatment of Complicated Skin and Soft Tissue Infections with Daptomycin: Results from a Large European Registry (EU-CORE)
por: Cogo, Alberto, et al.
Publicado: (2015) -
Daptomycin for the treatment of osteomyelitis and orthopaedic device infections: real-world clinical experience from a European registry
por: Malizos, K., et al.
Publicado: (2015)